A new metabolomic assay to examine inflammation and redox pathways following LPS challenge

di Suh, Jung H, Kim, Robert Y, Lee, Daniel S
Pubblicazione 2012

Optimal Planning Target Volume Margins for Elective Pelvic Lymphatic Radiotherapy in High-Risk Prostate Cancer Patients

di Hinton, Benjamin K., Fiveash, John B., Wu, Xingen, Dobelbower, Michael C., Kim, Robert Y., Jacob, Rojymon
Pubblicazione 2013

Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry

di McDonald, Andrew M., Bishop, Justin M., Jacob, Rojymon, Dobelbower, Michael C., Kim, Robert Y., Yang, Eddy S., Smith, Heather, Wu, Xingen, Fiveash, John B.
Pubblicazione 2012

Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiothera...

di McDonald, Andrew M, Baker, Christopher B, Popple, Richard A, Shekar, Kiran, Yang, Eddy S, Jacob, Rojymon, Cardan, Rex, Kim, Robert Y, Fiveash, John B
Pubblicazione 2014

Reduced Radiation Tolerance of Penile Structures Associated With Dose-escalated Hypofractionated Prostate Radiotherapy

di McDonald, Andrew M., Baker, Christopher B., Shekar, Kiran, Popple, Richard A., Clark, Grant M., Yang, Eddy S., Jacob, Rojymon, Kim, Robert Y., Fiveash, John B.
Pubblicato in Urology (2014)

Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial

di McDonald, Andrew M., Dobelbower, Michael C., Yang, Eddy S., Clark, Grant M., Jacob, Rojymon, Kim, Robert Y., Cardan, Rex A., Popple, Richard, Nix, Jeffrey W., Rais-Bahrami, Soroush, Fiveash, John B.
Pubblicato in Adv Radiat Oncol (2018)